| | POLISH FINANCIAL SUPERVISION AUTHORITY | |
| |
| | | UNI - EN REPORT No | 22 | / | 2014 |
| | |
| | Date of issue: | 2014-02-20 | | | | | | | | |
| | Short name of the issuer | | | | | | | |
| | SOPHARMA AD | |
| | Subject | | | | | | | | | | |
| | Current report 22 buy back 20022014 | |
| | Official market - legal basis | | | | | | |
| | Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne
| |
| | Unofficial market - legal basis | | | | | |
| | Contents of the report: | | | | | | | | |
| | SOPHARMA AD (the “Company") hereby informs that from 13 February 2014 up to and including 19 February 2014 the Company bought 1 500 own shares representing 0.0011% of the share capital of the Company, to the total value of 6 420.00 BGN on the Bulgarian Stock Exchange, the average price per share was 4.28 BGN.
The shares have been bought on the basis of decision No. 7 of the Annual General Meeting of Shareholders from 23 June 2010.
The total number of treasury shares after these transactions is 5 029 373, representing 3.81% of the share capital of the Company.
| |
| | Annexes | | | | | | | | | | |
| | File | Description | |
| | Current report 22 buy back 20022014.doc
| Current report 22 buy back 20022014 | |
